Iradimed (IRMD) EBIT Growth (3y) (2016 - 2026)
Powered by 
Analysis
Iradimed (IRMD) EBIT Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 3.16% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 28.02% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 11.63% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 19.80% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 31.84% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 24.88% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -65.59% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 35.44% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 13.06% |
| 10 | Iradimed | 1.07 Bn | 1.01 Bn | 15.16 Mn | 8.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.79% |
| Mar 31, 2026 | 21.78% |
| Dec 31, 2025 | 18.59% |
| Sep 30, 2025 | 18.26% |
| Jun 30, 2025 | 17.67% |
| Mar 31, 2025 | 20.89% |
| Dec 31, 2024 | 23.10% |
| Sep 30, 2024 | 23.32% |
| Jun 30, 2024 | 45.04% |
| Mar 31, 2024 | 38.77% |
| Dec 31, 2023 | 99.38% |
| Sep 30, 2023 | 95.96% |
| Jun 30, 2023 | 54.59% |
| Mar 31, 2023 | 75.82% |
| Dec 31, 2022 | 23.86% |
| Sep 30, 2022 | 17.94% |
| Jun 30, 2022 | 20.59% |
| Mar 31, 2022 | 26.64% |
| Dec 31, 2021 | 20.15% |
| Sep 30, 2021 | 28.70% |